US FDA grants fast track designation to Pfizer’s ervogastat/clesacostat combination to treat NASH Read more
USFDA grants Zydus fast track designation for Saroglitazar to treat primary biliary cholangitis Read more
Xeris Pharma gets US FDA fast track designation for diazepam non-aqueous injection to treat acute repetitive seizures Read more